Literature DB >> 23164461

The cost of depression - a cost analysis from a large database.

Katja Kleine-Budde1, Romina Müller, Wolfram Kawohl, Anke Bramesfeld, Jörn Moock, Wulf Rössler.   

Abstract

BACKGROUND: Depression poses a serious economic problem. We performed a cost-of-illness study using data from a German health insurance company to determine which costs are unique to that disease.
METHODS: The analysis included every adult and continuously insured person. Using claims data from 2007 to 2009, we calculated the costs incurred by persons with depression, including services provided for inpatient and outpatient care, drugs and psychiatric outpatient clinics. Subgroup analyses were done using demographic and disease-specific variables. Longitudinal predictors of depression-related costs were obtained through a generalized estimating equations (GEE) analysis.
RESULTS: This investigation involved 117,220 persons. Mean annual depression-specific costs per person were €458.9, with those costs decreasing over the study period. The main cost component (43.9% of the total) was inpatient care. It was found that persons with a severe course of disease and unemployed persons are more costly than other persons. The GEE analysis revealed that gender, age, residency within an urban area, occupational status and the type of diagnosis had a significant impact on these costs. LIMITATIONS: Due to data constraints, we were unable to include all cost categories that might be related to depression and we had no control group of persons without depression.
CONCLUSIONS: Due to the influence of the severity of the disease on costs, effective treatment strategies are important in order to prevent a progression of the disease and an increase in costs.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23164461     DOI: 10.1016/j.jad.2012.10.024

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  17 in total

1.  Longterm persistence and nonrecurrence of depression treatment in Germany: a four-year retrospective follow-up using linked claims data.

Authors:  Christoph J Wagner; Charalabos Markos Dintsios; Florian G Metzger; Helmut L'Hoest; Ursula Marschall; Bjoern Stollenwerk; Stephanie Stock
Journal:  Int J Methods Psychiatr Res       Date:  2018-02-15       Impact factor: 4.035

2.  Health care costs of borderline personality disorder and matched controls with major depressive disorder: a comparative study based on anonymized claims data.

Authors:  Katharina Bode; Rolf Vogel; Jochen Walker; Christoph Kröger
Journal:  Eur J Health Econ       Date:  2016-12-18

3.  The Role of Self-Compassion in Buffering Symptoms of Depression in the General Population.

Authors:  Annett Körner; Adina Coroiu; Laura Copeland; Carlos Gomez-Garibello; Cornelia Albani; Markus Zenger; Elmar Brähler
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

4.  Long-term effects of the treatment of depressive female inpatients in a naturalistic study: is early improvement a valid predictor of outcome?

Authors:  Elian Zuercher-Huerlimann; Martin Grosse Holtforth; Ernst Hermann
Journal:  Depress Res Treat       Date:  2014-06-30

5.  Resource utilisation and costs of depressive patients in Germany: results from the primary care monitoring for depressive patients trial.

Authors:  Christian Krauth; Jona T Stahmeyer; Juliana J Petersen; Antje Freytag; Ferdinand M Gerlach; Jochen Gensichen
Journal:  Depress Res Treat       Date:  2014-09-09

6.  Antidepressants: relationship to the time to psychiatric readmission and probability of being in hospital in depressive patients.

Authors:  Ingeborg Warnke; Carlos Nordt; Jörn Moock; Wolfram Kawohl; Wulf Rössler
Journal:  Front Public Health       Date:  2014-05-08

7.  The direct healthcare costs associated with psychological distress and major depression: A population-based cohort study in Ontario, Canada.

Authors:  Maria Chiu; Michael Lebenbaum; Joyce Cheng; Claire de Oliveira; Paul Kurdyak
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

Review 8.  Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.

Authors:  Carola Rong; Caroline Park; Joshua D Rosenblat; Mehala Subramaniapillai; Hannah Zuckerman; Dominika Fus; Yena L Lee; Zihang Pan; Elisa Brietzke; Rodrigo B Mansur; Danielle S Cha; Leanna M W Lui; Roger S McIntyre
Journal:  Int J Environ Res Public Health       Date:  2018-04-17       Impact factor: 3.390

Review 9.  Support from the Internet for Individuals with Mental Disorders: Advantages and Disadvantages of e-Mental Health Service Delivery.

Authors:  Jörn Moock
Journal:  Front Public Health       Date:  2014-06-11

10.  Pattern of inpatient care for depression: an analysis of 232,289 admissions.

Authors:  Gernot Fugger; Thomas Waldhör; Barbara Hinterbuchinger; Nathalie Pruckner; Daniel König; Andrea Gmeiner; Sandra Vyssoki; Benjamin Vyssoki; Matthäus Fellinger
Journal:  BMC Psychiatry       Date:  2020-07-16       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.